Table 1.
Typical Mechanisms of lipid metabolism in fatty liver diseases.
| Type | Mode | Consequence | |
|---|---|---|---|
| Hormone | Insulin | Insulin binds to insulin receptor then activates PI3K-Akt pathway, consequently activates transcription factors such as FoxO family to promote lipogenic genes | Lipid synthesis |
| Thyroid hormone (TH) | TH interacts with its receptor and influence fatty uptake proteins to increase free fatty acids uptake. TH can also promote lipogenic transcription factor via MAPK/ERK and PI3K/Akt pathways. TH can promote lipid breakdown by lipase or lipophagy. | Lipid synthesis/ Lipid breakdown | |
| Transcription factor | SIRT1,3,6 | ||
| FoxO | FoxO protein stimulates triacylglycerol lipase and activates autophagy to promote lipid breakdown. Besides, FoxO6 has ability to export triglyceride from hepatic cells. | Inhibit lipogenesis and increase lipid breakdown | |
| SREBPs | Hepatic SREBP-1c mRNA elevates when given a high carbohydrate diet. SREBPs can be modulated by mTORC1. Besides SREBPs activities associate with ubiquitin-dependent proteasomal degradation. | Promote lipogenesis | |
| Inflammatory cytokine | IL-6 | IL-6 downregulates TNF-α and increase PPARα meanwhile up-regulates AMPK to exert lipolytic activity. | Promote lipid breakdown and ameliorate hepatic steatosis |
| TNF-α | TNF-α Presents together with nonalcoholic steatohepatitis | exacerbate liver damage and hepatic fat deposition |